Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

EFALIZUMAB for Pustular psoriasis: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 101 adverse event reports in the FDA FAERS database where EFALIZUMAB was used for Pustular psoriasis.

Most Reported Side Effects for EFALIZUMAB

Side Effect Reports % Deaths Hosp.
Death 56 24.4% 56 2
Psoriasis 55 23.9% 3 13
Pruritus 35 15.2% 8 1
Erythema 28 12.2% 4 0
Drug ineffective 26 11.3% 3 6
Pain 25 10.9% 10 1
Decreased appetite 24 10.4% 0 0
Hypersensitivity 24 10.4% 1 1
Vomiting 24 10.4% 0 2
Nausea 23 10.0% 1 0
Condition aggravated 22 9.6% 0 8
Myalgia 22 9.6% 0 0
Fatigue 20 8.7% 0 0
Skin exfoliation 19 8.3% 5 0
Skin plaque 12 5.2% 6 0

Other Indications for EFALIZUMAB

Psoriasis (157) Product used for unknown indication (51) Psoriatic arthropathy (8)

Other Drugs Used for Pustular psoriasis

APREMILAST (349) SECUKINUMAB (317) ADALIMUMAB (207) METHOTREXATE (159) CYCLOSPORINE (157) ETANERCEPT (146) INFLIXIMAB (144) ACITRETIN (129) USTEKINUMAB (120) IXEKIZUMAB (81)

Related Pages

EFALIZUMAB Full Profile All Pustular psoriasis Drugs EFALIZUMAB Demographics EFALIZUMAB Timeline